Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
bumetanide cystic fibrosis transmembrane conductance regulator small molecule NA drugbank Nephrotic Syndrome[MeSHID:D009404]
Congestive heart failure[MeSHID:D006333]
Edema[MeSHID:D004487]
Kidney Diseases[MeSHID:D007674]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved antagonist
bumetanide solute carrier family 12 member 1 small molecule Successful target TTD , drugbank , DGIDB Nephrotic Syndrome[MeSHID:D009404]
Congestive heart failure[MeSHID:D006333]
Edema[MeSHID:D004487]
Kidney Diseases[MeSHID:D007674]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 3.25 approved inhibitor
bumetanide solute carrier family 12 member 2 small molecule NA drugbank , DGIDB Nephrotic Syndrome[MeSHID:D009404]
Congestive heart failure[MeSHID:D006333]
Edema[MeSHID:D004487]
Kidney Diseases[MeSHID:D007674]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 12.12 approved inhibitor
bumetanide solute carrier family 12 member 4 small molecule NA drugbank , DGIDB Nephrotic Syndrome[MeSHID:D009404]
Congestive heart failure[MeSHID:D006333]
Edema[MeSHID:D004487]
Kidney Diseases[MeSHID:D007674]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 18.19 approved inhibitor
bumetanide solute carrier family 12 member 5 small molecule NA drugbank , DGIDB Nephrotic Syndrome[MeSHID:D009404]
Congestive heart failure[MeSHID:D006333]
Edema[MeSHID:D004487]
Kidney Diseases[MeSHID:D007674]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 13.64 approved inhibitor
click here to return to the previous page